According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Recombinant Carboxypeptidase B Market

The global market for Recombinant Carboxypeptidase B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Carboxypeptidase B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Carboxypeptidase B.

The Recombinant Carboxypeptidase B market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Carboxypeptidase B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Carboxypeptidase B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Carboxypeptidase B Market Report

Report Metric	Details
Report Name	Recombinant Carboxypeptidase B Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	＞90% ＞95% Others
Segment by Application	Functional Studies SDS-PAGE HPLC Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, PeproTech, Prospec Bio, BPS Bioscience, Shanghai Yaxin Biotechnology Co., Ltd., R&D Systems, RayBiotech, Abcam, Advent Bio, Innovative Researc, enQuire BioReagents, Lonza Bioscience, Boster Bio, ProSci
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Carboxypeptidase B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Carboxypeptidase B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Carboxypeptidase B Market report?

Ans: The main players in the Recombinant Carboxypeptidase B Market are Roche, PeproTech, Prospec Bio, BPS Bioscience, Shanghai Yaxin Biotechnology Co., Ltd., R&D Systems, RayBiotech, Abcam, Advent Bio, Innovative Researc, enQuire BioReagents, Lonza Bioscience, Boster Bio, ProSci

What are the Application segmentation covered in the Recombinant Carboxypeptidase B Market report?

Ans: The Applications covered in the Recombinant Carboxypeptidase B Market report are Functional Studies, SDS-PAGE, HPLC, Others

What are the Type segmentation covered in the Recombinant Carboxypeptidase B Market report?

Ans: The Types covered in the Recombinant Carboxypeptidase B Market report are ＞90%, ＞95%, Others

1 Recombinant Carboxypeptidase B Market Overview

1.1 Product Definition

1.2 Recombinant Carboxypeptidase B by Type

1.2.1 Global Recombinant Carboxypeptidase B Market Value Comparison by Type (2024 VS 2031)

1.2.2 ＞90%

1.2.3 ＞95%

1.2.4 Others

1.3 Recombinant Carboxypeptidase B by Application

1.3.1 Global Recombinant Carboxypeptidase B Market Value by Application (2024 VS 2031)

1.3.2 Functional Studies

1.3.3 SDS-PAGE

1.3.4 HPLC

1.3.5 Others

1.4 Global Recombinant Carboxypeptidase B Market Size Estimates and Forecasts

1.4.1 Global Recombinant Carboxypeptidase B Revenue 2020-2031

1.4.2 Global Recombinant Carboxypeptidase B Sales 2020-2031

1.4.3 Global Recombinant Carboxypeptidase B Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Recombinant Carboxypeptidase B Market Competition by Manufacturers

2.1 Global Recombinant Carboxypeptidase B Sales Market Share by Manufacturers (2020-2025)

2.2 Global Recombinant Carboxypeptidase B Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Recombinant Carboxypeptidase B Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Recombinant Carboxypeptidase B, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Carboxypeptidase B, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Carboxypeptidase B, Product Type & Application

2.7 Global Key Manufacturers of Recombinant Carboxypeptidase B, Date of Enter into This Industry

2.8 Global Recombinant Carboxypeptidase B Market Competitive Situation and Trends

2.8.1 Global Recombinant Carboxypeptidase B Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Recombinant Carboxypeptidase B Players Market Share by Revenue

2.8.3 Global Recombinant Carboxypeptidase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Recombinant Carboxypeptidase B Market Scenario by Region

3.1 Global Recombinant Carboxypeptidase B Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Recombinant Carboxypeptidase B Sales by Region: 2020-2031

3.2.1 Global Recombinant Carboxypeptidase B Sales by Region: 2020-2025

3.2.2 Global Recombinant Carboxypeptidase B Sales by Region: 2026-2031

3.3 Global Recombinant Carboxypeptidase B Revenue by Region: 2020-2031

3.3.1 Global Recombinant Carboxypeptidase B Revenue by Region: 2020-2025

3.3.2 Global Recombinant Carboxypeptidase B Revenue by Region: 2026-2031

3.4 North America Recombinant Carboxypeptidase B Market Facts & Figures by Country

3.4.1 North America Recombinant Carboxypeptidase B Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Recombinant Carboxypeptidase B Sales by Country (2020-2031)

3.4.3 North America Recombinant Carboxypeptidase B Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Carboxypeptidase B Market Facts & Figures by Country

3.5.1 Europe Recombinant Carboxypeptidase B Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Recombinant Carboxypeptidase B Sales by Country (2020-2031)

3.5.3 Europe Recombinant Carboxypeptidase B Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Carboxypeptidase B Market Facts & Figures by Region

3.6.1 Asia Pacific Recombinant Carboxypeptidase B Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Recombinant Carboxypeptidase B Sales by Region (2020-2031)

3.6.3 Asia Pacific Recombinant Carboxypeptidase B Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Recombinant Carboxypeptidase B Market Facts & Figures by Country

3.7.1 Latin America Recombinant Carboxypeptidase B Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Recombinant Carboxypeptidase B Sales by Country (2020-2031)

3.7.3 Latin America Recombinant Carboxypeptidase B Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Carboxypeptidase B Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Carboxypeptidase B Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Recombinant Carboxypeptidase B Sales by Country (2020-2031)

3.8.3 Middle East and Africa Recombinant Carboxypeptidase B Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Recombinant Carboxypeptidase B Sales by Type (2020-2031)

4.1.1 Global Recombinant Carboxypeptidase B Sales by Type (2020-2025)

4.1.2 Global Recombinant Carboxypeptidase B Sales by Type (2026-2031)

4.1.3 Global Recombinant Carboxypeptidase B Sales Market Share by Type (2020-2031)

4.2 Global Recombinant Carboxypeptidase B Revenue by Type (2020-2031)

4.2.1 Global Recombinant Carboxypeptidase B Revenue by Type (2020-2025)

4.2.2 Global Recombinant Carboxypeptidase B Revenue by Type (2026-2031)

4.2.3 Global Recombinant Carboxypeptidase B Revenue Market Share by Type (2020-2031)

4.3 Global Recombinant Carboxypeptidase B Price by Type (2020-2031)

5 Segment by Application

5.1 Global Recombinant Carboxypeptidase B Sales by Application (2020-2031)

5.1.1 Global Recombinant Carboxypeptidase B Sales by Application (2020-2025)

5.1.2 Global Recombinant Carboxypeptidase B Sales by Application (2026-2031)

5.1.3 Global Recombinant Carboxypeptidase B Sales Market Share by Application (2020-2031)

5.2 Global Recombinant Carboxypeptidase B Revenue by Application (2020-2031)

5.2.1 Global Recombinant Carboxypeptidase B Revenue by Application (2020-2025)

5.2.2 Global Recombinant Carboxypeptidase B Revenue by Application (2026-2031)

5.2.3 Global Recombinant Carboxypeptidase B Revenue Market Share by Application (2020-2031)

5.3 Global Recombinant Carboxypeptidase B Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Recombinant Carboxypeptidase B Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 PeproTech

6.2.1 PeproTech Company Information

6.2.2 PeproTech Description and Business Overview

6.2.3 PeproTech Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.2.4 PeproTech Recombinant Carboxypeptidase B Product Portfolio

6.2.5 PeproTech Recent Developments/Updates

6.3 Prospec Bio

6.3.1 Prospec Bio Company Information

6.3.2 Prospec Bio Description and Business Overview

6.3.3 Prospec Bio Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Prospec Bio Recombinant Carboxypeptidase B Product Portfolio

6.3.5 Prospec Bio Recent Developments/Updates

6.4 BPS Bioscience

6.4.1 BPS Bioscience Company Information

6.4.2 BPS Bioscience Description and Business Overview

6.4.3 BPS Bioscience Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BPS Bioscience Recombinant Carboxypeptidase B Product Portfolio

6.4.5 BPS Bioscience Recent Developments/Updates

6.5 Shanghai Yaxin Biotechnology Co., Ltd.

6.5.1 Shanghai Yaxin Biotechnology Co., Ltd. Company Information

6.5.2 Shanghai Yaxin Biotechnology Co., Ltd. Description and Business Overview

6.5.3 Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Product Portfolio

6.5.5 Shanghai Yaxin Biotechnology Co., Ltd. Recent Developments/Updates

6.6 R&D Systems

6.6.1 R&D Systems Company Information

6.6.2 R&D Systems Description and Business Overview

6.6.3 R&D Systems Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.6.4 R&D Systems Recombinant Carboxypeptidase B Product Portfolio

6.6.5 R&D Systems Recent Developments/Updates

6.7 RayBiotech

6.7.1 RayBiotech Company Information

6.7.2 RayBiotech Description and Business Overview

6.7.3 RayBiotech Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.7.4 RayBiotech Recombinant Carboxypeptidase B Product Portfolio

6.7.5 RayBiotech Recent Developments/Updates

6.8 Abcam

6.8.1 Abcam Company Information

6.8.2 Abcam Description and Business Overview

6.8.3 Abcam Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Abcam Recombinant Carboxypeptidase B Product Portfolio

6.8.5 Abcam Recent Developments/Updates

6.9 Advent Bio

6.9.1 Advent Bio Company Information

6.9.2 Advent Bio Description and Business Overview

6.9.3 Advent Bio Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Advent Bio Recombinant Carboxypeptidase B Product Portfolio

6.9.5 Advent Bio Recent Developments/Updates

6.10 Innovative Researc

6.10.1 Innovative Researc Company Information

6.10.2 Innovative Researc Description and Business Overview

6.10.3 Innovative Researc Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Innovative Researc Recombinant Carboxypeptidase B Product Portfolio

6.10.5 Innovative Researc Recent Developments/Updates

6.11 enQuire BioReagents

6.11.1 enQuire BioReagents Company Information

6.11.2 enQuire BioReagents Description and Business Overview

6.11.3 enQuire BioReagents Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.11.4 enQuire BioReagents Recombinant Carboxypeptidase B Product Portfolio

6.11.5 enQuire BioReagents Recent Developments/Updates

6.12 Lonza Bioscience

6.12.1 Lonza Bioscience Company Information

6.12.2 Lonza Bioscience Description and Business Overview

6.12.3 Lonza Bioscience Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Lonza Bioscience Recombinant Carboxypeptidase B Product Portfolio

6.12.5 Lonza Bioscience Recent Developments/Updates

6.13 Boster Bio

6.13.1 Boster Bio Company Information

6.13.2 Boster Bio Description and Business Overview

6.13.3 Boster Bio Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Boster Bio Recombinant Carboxypeptidase B Product Portfolio

6.13.5 Boster Bio Recent Developments/Updates

6.14 ProSci

6.14.1 ProSci Company Information

6.14.2 ProSci Description and Business Overview

6.14.3 ProSci Recombinant Carboxypeptidase B Sales, Revenue and Gross Margin (2020-2025)

6.14.4 ProSci Recombinant Carboxypeptidase B Product Portfolio

6.14.5 ProSci Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Carboxypeptidase B Industry Chain Analysis

7.2 Recombinant Carboxypeptidase B Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Carboxypeptidase B Production Mode & Process Analysis

7.4 Recombinant Carboxypeptidase B Sales and Marketing

7.4.1 Recombinant Carboxypeptidase B Sales Channels

7.4.2 Recombinant Carboxypeptidase B Distributors

7.5 Recombinant Carboxypeptidase B Customer Analysis

8 Recombinant Carboxypeptidase B Market Dynamics

8.1 Recombinant Carboxypeptidase B Industry Trends

8.2 Recombinant Carboxypeptidase B Market Drivers

8.3 Recombinant Carboxypeptidase B Market Challenges

8.4 Recombinant Carboxypeptidase B Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shanghai Yaxin Biotechnology Co., Ltd.

List of Tables

Table 1. Global Recombinant Carboxypeptidase B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Recombinant Carboxypeptidase B Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Recombinant Carboxypeptidase B Market Competitive Situation by Manufacturers in 2024

Table 4. Global Recombinant Carboxypeptidase B Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Recombinant Carboxypeptidase B Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Recombinant Carboxypeptidase B Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Recombinant Carboxypeptidase B Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Recombinant Carboxypeptidase B Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Recombinant Carboxypeptidase B, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Carboxypeptidase B, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Carboxypeptidase B, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Carboxypeptidase B, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Carboxypeptidase B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Carboxypeptidase B as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Carboxypeptidase B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Recombinant Carboxypeptidase B Sales by Region (2020-2025) & (Tons)

Table 18. Global Recombinant Carboxypeptidase B Sales Market Share by Region (2020-2025)

Table 19. Global Recombinant Carboxypeptidase B Sales by Region (2026-2031) & (Tons)

Table 20. Global Recombinant Carboxypeptidase B Sales Market Share by Region (2026-2031)

Table 21. Global Recombinant Carboxypeptidase B Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Recombinant Carboxypeptidase B Revenue Market Share by Region (2020-2025)

Table 23. Global Recombinant Carboxypeptidase B Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Recombinant Carboxypeptidase B Revenue Market Share by Region (2026-2031)

Table 25. North America Recombinant Carboxypeptidase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Recombinant Carboxypeptidase B Sales by Country (2020-2025) & (Tons)

Table 27. North America Recombinant Carboxypeptidase B Sales by Country (2026-2031) & (Tons)

Table 28. North America Recombinant Carboxypeptidase B Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Recombinant Carboxypeptidase B Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Recombinant Carboxypeptidase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Recombinant Carboxypeptidase B Sales by Country (2020-2025) & (Tons)

Table 32. Europe Recombinant Carboxypeptidase B Sales by Country (2026-2031) & (Tons)

Table 33. Europe Recombinant Carboxypeptidase B Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Recombinant Carboxypeptidase B Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Recombinant Carboxypeptidase B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Recombinant Carboxypeptidase B Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Recombinant Carboxypeptidase B Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Recombinant Carboxypeptidase B Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Recombinant Carboxypeptidase B Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Recombinant Carboxypeptidase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Recombinant Carboxypeptidase B Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Recombinant Carboxypeptidase B Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Recombinant Carboxypeptidase B Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Recombinant Carboxypeptidase B Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Recombinant Carboxypeptidase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Recombinant Carboxypeptidase B Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Recombinant Carboxypeptidase B Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Recombinant Carboxypeptidase B Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Recombinant Carboxypeptidase B Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Recombinant Carboxypeptidase B Sales (Tons) by Type (2020-2025)

Table 51. Global Recombinant Carboxypeptidase B Sales (Tons) by Type (2026-2031)

Table 52. Global Recombinant Carboxypeptidase B Sales Market Share by Type (2020-2025)

Table 53. Global Recombinant Carboxypeptidase B Sales Market Share by Type (2026-2031)

Table 54. Global Recombinant Carboxypeptidase B Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Recombinant Carboxypeptidase B Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Recombinant Carboxypeptidase B Revenue Market Share by Type (2020-2025)

Table 57. Global Recombinant Carboxypeptidase B Revenue Market Share by Type (2026-2031)

Table 58. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Type (2020-2025)

Table 59. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Type (2026-2031)

Table 60. Global Recombinant Carboxypeptidase B Sales (Tons) by Application (2020-2025)

Table 61. Global Recombinant Carboxypeptidase B Sales (Tons) by Application (2026-2031)

Table 62. Global Recombinant Carboxypeptidase B Sales Market Share by Application (2020-2025)

Table 63. Global Recombinant Carboxypeptidase B Sales Market Share by Application (2026-2031)

Table 64. Global Recombinant Carboxypeptidase B Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Recombinant Carboxypeptidase B Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Recombinant Carboxypeptidase B Revenue Market Share by Application (2020-2025)

Table 67. Global Recombinant Carboxypeptidase B Revenue Market Share by Application (2026-2031)

Table 68. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Application (2020-2025)

Table 69. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Application (2026-2031)

Table 70. Roche Company Information

Table 71. Roche Description and Business Overview

Table 72. Roche Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Roche Recombinant Carboxypeptidase B Product

Table 74. Roche Recent Developments/Updates

Table 75. PeproTech Company Information

Table 76. PeproTech Description and Business Overview

Table 77. PeproTech Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. PeproTech Recombinant Carboxypeptidase B Product

Table 79. PeproTech Recent Developments/Updates

Table 80. Prospec Bio Company Information

Table 81. Prospec Bio Description and Business Overview

Table 82. Prospec Bio Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Prospec Bio Recombinant Carboxypeptidase B Product

Table 84. Prospec Bio Recent Developments/Updates

Table 85. BPS Bioscience Company Information

Table 86. BPS Bioscience Description and Business Overview

Table 87. BPS Bioscience Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. BPS Bioscience Recombinant Carboxypeptidase B Product

Table 89. BPS Bioscience Recent Developments/Updates

Table 90. Shanghai Yaxin Biotechnology Co., Ltd. Company Information

Table 91. Shanghai Yaxin Biotechnology Co., Ltd. Description and Business Overview

Table 92. Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Product

Table 94. Shanghai Yaxin Biotechnology Co., Ltd. Recent Developments/Updates

Table 95. R&D Systems Company Information

Table 96. R&D Systems Description and Business Overview

Table 97. R&D Systems Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. R&D Systems Recombinant Carboxypeptidase B Product

Table 99. R&D Systems Recent Developments/Updates

Table 100. RayBiotech Company Information

Table 101. RayBiotech Description and Business Overview

Table 102. RayBiotech Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. RayBiotech Recombinant Carboxypeptidase B Product

Table 104. RayBiotech Recent Developments/Updates

Table 105. Abcam Company Information

Table 106. Abcam Description and Business Overview

Table 107. Abcam Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Abcam Recombinant Carboxypeptidase B Product

Table 109. Abcam Recent Developments/Updates

Table 110. Advent Bio Company Information

Table 111. Advent Bio Description and Business Overview

Table 112. Advent Bio Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Advent Bio Recombinant Carboxypeptidase B Product

Table 114. Advent Bio Recent Developments/Updates

Table 115. Innovative Researc Company Information

Table 116. Innovative Researc Description and Business Overview

Table 117. Innovative Researc Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Innovative Researc Recombinant Carboxypeptidase B Product

Table 119. Innovative Researc Recent Developments/Updates

Table 120. enQuire BioReagents Company Information

Table 121. enQuire BioReagents Description and Business Overview

Table 122. enQuire BioReagents Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. enQuire BioReagents Recombinant Carboxypeptidase B Product

Table 124. enQuire BioReagents Recent Developments/Updates

Table 125. Lonza Bioscience Company Information

Table 126. Lonza Bioscience Description and Business Overview

Table 127. Lonza Bioscience Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Lonza Bioscience Recombinant Carboxypeptidase B Product

Table 129. Lonza Bioscience Recent Developments/Updates

Table 130. Boster Bio Company Information

Table 131. Boster Bio Description and Business Overview

Table 132. Boster Bio Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Boster Bio Recombinant Carboxypeptidase B Product

Table 134. Boster Bio Recent Developments/Updates

Table 135. ProSci Company Information

Table 136. ProSci Description and Business Overview

Table 137. ProSci Recombinant Carboxypeptidase B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. ProSci Recombinant Carboxypeptidase B Product

Table 139. ProSci Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Recombinant Carboxypeptidase B Distributors List

Table 143. Recombinant Carboxypeptidase B Customers List

Table 144. Recombinant Carboxypeptidase B Market Trends

Table 145. Recombinant Carboxypeptidase B Market Drivers

Table 146. Recombinant Carboxypeptidase B Market Challenges

Table 147. Recombinant Carboxypeptidase B Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Recombinant Carboxypeptidase B

Figure 2. Global Recombinant Carboxypeptidase B Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant Carboxypeptidase B Market Share by Type: 2024 & 2031

Figure 4. ＞90% Product Picture

Figure 5. ＞95% Product Picture

Figure 6. Others Product Picture

Figure 7. Global Recombinant Carboxypeptidase B Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Recombinant Carboxypeptidase B Market Share by Application: 2024 & 2031

Figure 9. Functional Studies

Figure 10. SDS-PAGE

Figure 11. HPLC

Figure 12. Others

Figure 13. Global Recombinant Carboxypeptidase B Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Recombinant Carboxypeptidase B Market Size (2020-2031) & (US$ Million)

Figure 15. Global Recombinant Carboxypeptidase B Sales (2020-2031) & (Tons)

Figure 16. Global Recombinant Carboxypeptidase B Average Price (US$/Ton) & (2020-2031)

Figure 17. Recombinant Carboxypeptidase B Report Years Considered

Figure 18. Recombinant Carboxypeptidase B Sales Share by Manufacturers in 2024

Figure 19. Global Recombinant Carboxypeptidase B Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Recombinant Carboxypeptidase B Players: Market Share by Revenue in Recombinant Carboxypeptidase B in 2024

Figure 21. Recombinant Carboxypeptidase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Recombinant Carboxypeptidase B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Recombinant Carboxypeptidase B Sales Market Share by Country (2020-2031)

Figure 24. North America Recombinant Carboxypeptidase B Revenue Market Share by Country (2020-2031)

Figure 25. United States Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Recombinant Carboxypeptidase B Sales Market Share by Country (2020-2031)

Figure 28. Europe Recombinant Carboxypeptidase B Revenue Market Share by Country (2020-2031)

Figure 29. Germany Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Recombinant Carboxypeptidase B Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Recombinant Carboxypeptidase B Revenue Market Share by Region (2020-2031)

Figure 36. China Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Recombinant Carboxypeptidase B Sales Market Share by Country (2020-2031)

Figure 44. Latin America Recombinant Carboxypeptidase B Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Recombinant Carboxypeptidase B Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Recombinant Carboxypeptidase B Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Recombinant Carboxypeptidase B Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Recombinant Carboxypeptidase B by Type (2020-2031)

Figure 54. Global Revenue Market Share of Recombinant Carboxypeptidase B by Type (2020-2031)

Figure 55. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Type (2020-2031)

Figure 56. Global Sales Market Share of Recombinant Carboxypeptidase B by Application (2020-2031)

Figure 57. Global Revenue Market Share of Recombinant Carboxypeptidase B by Application (2020-2031)

Figure 58. Global Recombinant Carboxypeptidase B Price (US$/Ton) by Application (2020-2031)

Figure 59. Recombinant Carboxypeptidase B Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Animal Origin Free Recombinant Trypsin Market Research Report 2024

Global Recombinant Trypsin Market Insights Forecast to 2030

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Recombinant Trypsin Powder Market Insights Forecast to 2030

Global Recombinant Protein Industrial Reagents Market Research Report 2024

Global Recombinant Trypsin Solution Market Research Report 2025

Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Gene Recombinant Protein Market Research Report 2024

Global Recombinant Protein Expression System Market Research Report 2024

Global Recombinant Human Thrombin Protein Market Research Report 2024

Global Recombinant Therapeutic Protein Market Research Report 2025

Global Recombinant Porcine Trypsin Market Research Report 2024

Global Recombinant Carbonyl Reductase Market Research Report 2024

Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant PKB Akt Protein Market Research Report 2024

Global Prokaryotic Recombinant Protein Market Research Report 2024

Global Recombinant Trypsin Liquid Solution Market Insights Forecast to 2030

Global Human Procalcitonin Recombinant Protein Market Research Report 2024

Global Recombinant Protein Biological Research Reagents Market Research Report 2024

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19T19555

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30T17927

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L19449

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Metabolite Chemistry Reagents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-14103

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions